Thu 21'st Sep 2017
Agile Therapeutics Stock Analysis
Technical stock analysis for Thu 21'st Sep 2017
Buy candidate since 2017-09-19 Gain 3.86%
Agile Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.73% during the next 3 months and, with 90% probability hold a price between $2.35 and $4.17 at the end of this period.
Only positive signals in the chart today. Agile Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.71 and $3.44. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday September 19, 2017, which indicates further gains until a new top pivot has been found. Agile Therapeutics has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSI14 is 66 and the stock is currently not being overbought or oversold
Support & Resistance
Agile Therapeutics finds support from accumulated volume at $3.76. On the upside the stock meets some resistance just above today's level from accumulated volume at $3.83, $3.84 and $4.60.
The stock is about to test the resistance from accumulated volume at $3.83 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 3.55%. For the last week, the stock has had a daily average volatility of 4.69%.
Our recommended stoploss: $3.59 (-4.86%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
Trade AGRX CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service. Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).